FDA
approval
· 2012-10-15
FDA Approved: IRBESARTAN — Original Application (Alembic Pharmaceuticals Limited)
Summary
FDA approved Alembic Pharmaceuticals Limited's original ANDA for irbesartan, a generic angiotensin II receptor blocker for hypertension and diabetic nephropathy…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for IRBESARTAN (IRBESARTAN)